Results
1 -
6 of
6
(Click
here to explore results)
- Functionalized nanomaterials targeting NLRP3 inflammasome driven immunomodulation: Friend or Foe. Kanika, Rehan Khan
, Nanoscale
, 2023
, 15
, 15906
- Euphopias D–F from Euphorbia L.: quantum chemical calculation-based structure elucidation and their bioactivity of inhibiting NLRP3 inflammasome activation. Qiang-Qiang Shi, Yu Zhang, Ting-Ting Wang, Feng Xiong, Rui-Han Zhang, Xiao-Li Li, Xu Ji, Xing-Jie Zhang, Wei-Guang Wang, Wei-Lie Xiao
, Org. Chem. Front.
, 2021
, 8
, 3041
- Druggable targets for the immunopathy of Alzheimer's disease. Donald F. Weaver
, RSC Med. Chem.
, 2023
, 14
, 1645
- Concurrent suppression of Aβ aggregation and NLRP3 inflammasome activation for treating Alzheimer's disease. Tao Yang, Lei Zhang, Yicun Shang, Zhenzhu Zhu, Suxing Jin, Zijian Guo, Xiaoyong Wang
, Chem. Sci.
, 2022
, 13
, 2971
- Sennoside A is a novel inhibitor targeting caspase-1. Jiasi Wu, Yuejia Lan, Xiaoke Shi, Wenge Huang, Sheng Li, Jizhou Zhang, Huan Wang, Fei Wang, Xianli Meng
, Food Funct.
, 2022
, 13
, 9782
- Diterpenoids with a novel 6/5-5 spiro tricyclic skeleton from Orthosiphon wulfenioides and their NLRP3 inflammasome inhibitory activity. Wen-Chao Tu, Xing-Jie Zhang, Ying-Xin Zhao, Wei-Chi Chen, Xing-Yu Zhang, Chang-Lin Yang, Muhammad Aurang Zeb, Xiao-Li Li, Kaunda-Joseph Sakah, Rui-Han Zhang, Mei-Feng Liu, Wei-Lie Xiao
, Org. Chem. Front.
, 2023
, 10
, 2898